Neogen Corporation (NEOG) Financials
NEOG Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-02-29 | 4.6 billion | 1.4 billion |
| 2023-11-30 | 4.6 billion | 1.5 billion |
| 2023-08-31 | 4.6 billion | 1.4 billion |
| 2023-05-31 | 4.6 billion | 1.4 billion |
NEOG Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-02-29 | -62.3 million | 3.7 million |
| 2023-11-30 | -8.7 million | 3.5 million |
| 2023-08-31 | -7.6 million | 2.6 million |
| 2023-05-31 | 65.5 million | 2.9 million |
NEOG Net Income
Graph available only for supporters. Become a supporter to see it.
| Date | Net Income |
|---|---|
| 2024-02-29 | -2.0 million |
| 2023-11-30 | -3.5 million |
| 2023-08-31 | 1.5 million |
| 2023-05-31 | 5.6 million |
NEOG Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-02-29 | 168.4 million | - | 2.5 million |
| 2023-11-30 | 230.3 million | - | 2.6 million |
| 2023-08-31 | 239.3 million | - | 2.6 million |
| 2023-05-31 | 245.6 million | - | - |
NEOG Shares Outstanding
NEOG Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-02-29 | 32.1 million | 4.9 million | 52.1 million | 47.9 million |
| 2023-11-30 | 24.4 million | 5.8 million | 51.7 million | 44.8 million |
| 2023-08-31 | 30.6 million | 6.7 million | 45.1 million | 45.8 million |
| 2023-05-31 | 25.5 million | 7.1 million | 49.8 million | 42.9 million |
NEOG Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-02-29 | 228.8 million | 111.9 million |
| 2023-11-30 | 229.6 million | 112.9 million |
| 2023-08-31 | 229.0 million | 112.2 million |
| 2023-05-31 | 241.8 million | 118.6 million |
NEOG
Price: $12.14
52 week price:
Earnings Per Share: 0.10 USD
P/E Ratio: 165.50
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 1.5 million
Ebitda: 22.3 millionMarket Capitalization: 2.7 billion